One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Biological Imaging Reagents Market

Biological Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents, and Nuclear Reagents; Modality: MRI, Ultrasound, X-ray & CT, Nuclear, Optical Imaging, and Others; Application: In Vitro and In Vivo; End User: Diagnostic Laboratories, Imaging Centers, Life Science Companies, Research & Academic Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027


Product Code : TMRHC00110758
Survey : Transparency Market Research
Publish On : 20, May, 2022
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5795 / Question Form
5 User USD8795 / Question Form
Enterprise User USD11795 / Question Form

Bayer AG
Thermo Fisher Scientific, Inc.
PerkinElmer, Inc.
Guerbet
Lantheus Holdings, Inc.
Bracco S.p.A.
GE Healthcare
Becton, Dickinson and Company (BD)
Siemens Healthineers
Luminex Corporation

[Report Description]

Biological Imaging Reagents Market - Scope of the Report

TMR’S report on the global biological imaging reagents market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market for the forecast period of 2019 to 2027. The report provides the overall market revenue of the global biological imaging reagents market for the period of 2017 to 2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global biological imaging reagents market for the forecast period.

The report has been prepared after extensive primary and secondary research. Primary research involved bulk of the research efforts, wherein, analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global biological imaging reagents market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of the top-down and bottom-up approaches to study various phenomena in the global biological imaging reagents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global biological imaging reagents market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global biological imaging reagents market.

The report delves into the competitive landscape of the global biological imaging reagents market. Key players operating in the global biological imaging reagents market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global biological imaging reagents market that have been profiled in this report.

Key Questions Answered in the Biological Imaging Reagents Market Report

What is the sales/revenue expected to be generated by each class and modality segment of the biological imaging reagents market across all regions during the forecast period?
What are the opportunities in the global biological imaging reagents market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which region is likely to expand at the fastest CAGR during the forecast period?
Which biological imaging reagent class and modality segment are expected to generate the highest revenue, globally, in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market share or position of different companies operating in the global market in 2018?
Biological Imaging Reagents Market - Research Objectives and Research Approach

The comprehensive report on the global biological imaging reagents market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, regulatory scenario, technological advancements, and disease prevalence rate of different diseases and conditions.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of the actual and projected values of key segments is visually appealing to readers. This also allows the comparison of the market shares of key segments in the past and at the end of the forecast period.

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Biological Imaging Reagents Market

4. Market Overview

4.1. Introduction

4.1.1. Class Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

4.5. Porter’s Five Force Analysis

5. Market Outlook

5.1. Regulatory Scenario by Region/globally

5.2. Technological Advancements

5.3. Disease Prevalence & Incidence Rate globally with key countries

6. Global Biological Imaging Reagents Market Analysis and Forecast, by Class, 2017–2027

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Class, 2017–2027

6.3.1. Contrast Reagents

6.3.2. Optical Reagents

6.3.3. Nuclear Reagents

6.4. Market Attractiveness, by Class

7. Global Biological Imaging Reagents Market Analysis and Forecast, by Modality, 2017–2027

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Modality, 2017–2027

7.3.1. MRI

7.3.2. Ultrasound

7.3.3. X-ray & CT

7.3.4. Nuclear

7.3.4.1. PET

7.3.4.2. SPECT

7.3.5. Optical Imaging

7.3.6. Others

7.4. Market Attractiveness, by Modality

8. Global Biological Imaging Reagents Market Analysis and Forecast, by Application

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Application, 2017–2027

8.3.1. In Vitro

8.3.1.1. Proteomics

8.3.1.2. Genomics

8.3.1.3. Cell Biology

8.3.2. In Vivo

8.4. Market Attractiveness, by Application

9. Global Biological Imaging Reagents Market Analysis and Forecast, by End-user, 2017–2027

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Market Value Forecast, by End-user, 2017–2027

9.3.1. Diagnostic Laboratories

9.3.2. Imaging Centers

9.3.3. Life Sciences Companies

9.3.4. Academic & Research Institutes

9.3.5. Others

9.4. Market Attractiveness, by End-user

10. Global Biological Imaging Reagents Market Analysis and Forecasts, by Region, 2017–2027

10.1. Key Findings

10.2. Market Value Forecast, by Region

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Market Attractiveness, by Country/Region

11. North America Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

11.1.Introduction

11.1.1. Key Findings

11.2. Market Value Forecast, by Class, 2017–2027

11.2.1. Contrast Reagents

11.2.2. Optical Reagents

11.2.3. Nuclear Reagents

11.3. Market Value Forecast, by Modality, 2017–2027

11.3.1. MRI

11.3.2. Ultrasound

11.3.3. X-ray & CT

11.3.4. Nuclear

11.3.4.1. PET

11.3.4.2. SPECT

11.3.5. Optical Imaging

11.3.6. Others

11.4. Market Value Forecast, by Application, 2017–2027

11.4.1. In Vitro

11.4.1.1. Proteomics

11.4.1.2. Genomics

11.4.1.3. Cell Biology

11.4.2. In Vivo

11.5. Market Value Forecast, by End-user, 2017–2027

11.5.1. Diagnostic Laboratories

11.5.2. Imaging Centers

11.5.3. Life Sciences Companies

11.5.4. Academic & Research Institutes

11.5.5. Others

11.6. Market Value Forecast, by Country, 2017–2027

11.6.1. U.S.

11.6.2. Canada

11.7. Market Attractiveness Analysis

11.7.1. By Class

11.7.2. By Modality

11.7.3. By Application

11.7.4. By End-user

11.7.5. By Country

12. Europe Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast, by Class, 2017–2027

12.2.1. Contrast Reagents

12.2.2. Optical Reagents

12.2.3. Nuclear Reagents

12.3. Market Value Forecast, by Modality, 2017–2027

12.3.1. MRI

12.3.2. Ultrasound

12.3.3. X-ray & CT

12.3.4. Nuclear

12.3.4.1. PET

12.3.4.2. SPECT

12.3.5. Optical Imaging

12.3.6. Others

12.4. Market Value Forecast, by Application, 2017–2027

12.4.1. In Vitro

12.4.1.1. Proteomics

12.4.1.2. Genomics

12.4.1.3. Cell Biology

12.4.2. In Vivo

12.5. Market Value Forecast, by End-user, 2017–2027

12.5.1. Diagnostic Laboratories

12.5.2. Imaging Centers

12.5.3. Life Sciences Companies

12.5.4. Academic & Research Institutes

12.5.5. Others

12.6. Market Value Forecast, by Country/Sub-region, 2017–2027

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Market Attractiveness Analysis

12.7.1. By Class

12.7.2. By Modality

12.7.3. By Application

12.7.4. By End-user

12.7.5. By Country/Sub-region

13. Asia Pacific Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast, by Class, 2017–2027

13.2.1. Contrast Reagents

13.2.2. Optical Reagents

13.2.3. Nuclear Reagents

13.3. Market Value Forecast, by Modality, 2017–2027

13.3.1. MRI

13.3.2. Ultrasound

13.3.3. X-ray & CT

13.3.4. Nuclear

13.3.4.1. PET

13.3.4.2. SPECT

13.3.5. Optical Imaging

13.3.6. Others

13.4. Market Value Forecast, by Application, 2017–2027

13.4.1. In Vitro

13.4.1.1. Proteomics

13.4.1.2. Genomics

13.4.1.3. Cell Biology

13.4.2. In Vivo

13.5. Market Value Forecast, by End-user, 2017–2027

13.5.1. Diagnostic Laboratories

13.5.2. Imaging Centers

13.5.3. Life Sciences Companies

13.5.4. Academic & Research Institutes

13.5.5. Others

13.6. Market Value Forecast, by Country/Sub-region, 2017–2027

13.6.1. China

13.6.2. Japan

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Market Attractiveness Analysis

13.7.1. By Class

13.7.2. By Modality

13.7.3. By Application

13.7.4. By End-user

13.7.5. By Country/Sub-region

14. Latin America Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

14.1. Introduction

14.1.1. Key Findings

14.2. Market Value Forecast, by Class, 2017–2027

14.2.1. Contrast Reagents

14.2.2. Optical Reagents

14.2.3. Nuclear Reagents

14.3. Market Value Forecast, by Modality, 2017–2027

14.3.1. MRI

14.3.2. Ultrasound

14.3.3. X-ray & CT

14.3.4. Nuclear

14.3.4.1. PET

14.3.4.2. SPECT

14.3.5. Optical Imaging

14.3.6. Others

14.4. Market Value Forecast, by Application, 2017–2027

14.4.1. In Vitro

14.4.1.1. Proteomics

14.4.1.2. Genomics

14.4.1.3. Cell Biology

14.4.2. In Vivo

14.5. Market Value Forecast, by End-user, 2017–2027

14.5.1. Diagnostic Laboratories

14.5.2. Imaging Centers

14.5.3. Life Sciences Companies

14.5.4. Academic & Research Institutes

14.5.5. Others

14.6. Market Value Forecast, by Country/Sub-region, 2017–2027

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Market Attractiveness Analysis

14.7.1. By Class

14.7.2. By Modality

14.7.3. By Application

14.7.4. By End-user

14.7.5. By Country/Sub-region

15. Middle East & Africa Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

15.1. Introduction

15.1.1. Key Findings

15.2. Market Value Forecast, by Class, 2017–2027

15.2.1. Contrast Reagents

15.2.2. Optical Reagents

15.2.3. Nuclear Reagents

15.3. Market Value Forecast, by Modality, 2017–2027

15.3.1. MRI

15.3.2. Ultrasound

15.3.3. X-ray & CT

15.3.4. Nuclear

15.3.4.1. PET

15.3.4.2. SPECT

15.3.5. Optical Imaging

15.3.6. Others

15.4. Market Value Forecast, by Application, 2017–2027

15.4.1. In Vitro

15.4.1.1. Proteomics

15.4.1.2. Genomics

15.4.1.3. Cell Biology

15.4.2. In Vivo

15.5. Market Value Forecast, by End-user, 2017–2027

15.5.1. Diagnostic Laboratories

15.5.2. Imaging Centers

15.5.3. Life Sciences Companies

15.5.4. Academic & Research Institutes

15.5.5. Others

15.6. Market Value Forecast, by Country/Sub-region, 2017–2027

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Rest of Middle East & Africa

15.7. Market Attractiveness Analysis

15.7.1. By Class

15.7.2. By Modality

15.7.3. By Application

15.7.4. By End-user

15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player - Competition Matrix (By Tier and Size of companies)

16.2. Market Position/Ranking Analysis, by Company (2018)

16.3. Company Profiles

16.3.1. Bayer AG

16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.1.2. Company Financials

16.3.1.3. Growth Strategies

16.3.1.4. SWOT Analysis

16.3.2. Thermo Fisher Scientific, Inc.

16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.2.2. Company Financials

16.3.2.3. Growth Strategies

16.3.2.4. SWOT Analysis

16.3.3. PerkinElmer, Inc.

16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.3.2. Company Financials

16.3.3.3. Growth Strategies

16.3.3.4. SWOT Analysis

16.3.4. Guerbet

16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.4.2. Company Financials

16.3.4.3. Growth Strategies

16.3.4.4. SWOT Analysis

16.3.5. Lantheus Holdings, Inc.

16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.5.2. Company Financials

16.3.5.3. Growth Strategies

16.3.5.4. SWOT Analysis

16.3.6. Bracco S.p.A.

16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.6.2. Company Financials

16.3.6.3. Growth Strategies

16.3.6.4. SWOT Analysis

16.3.7. GE Healthcare

16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.7.2. Company Financials

16.3.7.3. Growth Strategies

16.3.7.4. SWOT Analysis

16.3.8. Becton, Dickinson and Company (BD)

16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.8.2. Company Financials

16.3.8.3. Growth Strategies

16.3.8.4. SWOT Analysis

16.3.9. Siemens Healthineers

16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.9.2. Company Financials

16.3.9.3. Growth Strategies

16.3.9.4. SWOT Analysis

16.3.10. Luminex Corporation

16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.10.2. Company Financials

16.3.10.3. Growth Strategies

16.3.10.4. SWOT Analysis

Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports

+